Analysts Set Pacira BioSciences, Inc. (NASDAQ:PCRX) PT at $47.40
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have received a consensus recommendation of “Buy” from the ten analysts that are currently covering the firm, Marketbeat Ratings reports. Ten research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock […]
More Stories
US Economy Rebounds With 2 Percent Growth in 1st Quarter
By Andrew Moran The U.S. economy registered a solid rebound in the first quarter after a disappointing end to 2025,...
Louisiana Governor Signals House Primaries Will Be Postponed After Supreme Court Redistricting Ruling
By Jacki Thrapp Louisiana plans to postpone U.S. House primaries in order to allow time for lawmakers to redraw and...
Top US General Signals Russia Is Helping Iran in War
By Jack Phillips The highest-ranking U.S. general on Thursday signaled that the Russian government is assisting the Iranian regime in...
Who is Chastity Nolan? Age, Husband, Children, and Social Media Updates
Have you watched videos of a mother-daughter duo while scrolling through your TikTok or Instagram account? That must be Chastity...
From Chaos to Control: How to Organize Your Life Like a Pro
Trying to stay organized, keeping on top of everything, from friends to family, social gatherings, events, and life admin, can...
Best Refrigerators in India 2026: Compare Top Models, Prices and Features
Choosing the right refrigerator is rarely just about price. Factors like energy efficiency, cooling technology, storage design, and smart features...